(Q63577854)
Statements
A PHASE 2B RANDOMIZED, DOUBLE‑BLIND, PLACEBO-CONTROLLED, PARALLEL, MULTICENTER, DOSE-RANGING, STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-04965842 IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS (English)
0 references
April 2016
0 references
March 2017
0 references
269
0 references
18 year
0 references
75 year
0 references